Announcements Trials
Browse Landscape

Phase

Phase 2 52Phase 1 18Phase 3 16Phase 1/2 8Phase 2/3 4Phase NA 3

Status

Completed 4Terminated 2Unknown 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3UNKNOWN 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 3Esophageal Neoplasms 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × S 1 (combination) × Clear all
NCT03607656 2023-12-18

CHANGE

Shanghai University of Traditional Chinese Medicine

Phase 2/3 Completed
270 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02979691 2020-07-21

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

ChineseAMS

Phase 2/3 Completed
350 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01516944 2020-02-13

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Hebei Medical University

Phase 2/3 Completed
749 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00639327 2011-06-28

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Japan Clinical Cancer Research Organization

Phase 2/3 Completed
300 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡